Press Release
- Services
- Press Release
Orchid Pharma Limited announced plans to strengthen its Active Pharmaceutical Ingredient (API) manufacturing capabilities through capacity expansion and new product initiatives, supporting its targeted revenue growth. Expanding API Manufacturing
India’s pharmaceutical manufacturing landscape is witnessing a significant capacity expansion as Neuland Laboratories announced plans to establish a new commercial-scale peptide manufacturing facility at its Bonthapally campus in Hyderabad. The
The global pharmaceutical industry continues to rely heavily on small molecule Active Pharmaceutical Ingredients (APIs), which account for a significant share of approved drugs worldwide. According to insights published on
The high-potency active pharmaceutical ingredient (HPAPI) segment is rapidly transforming the global pharmaceutical manufacturing landscape, driven by increasing demand for targeted therapies and complex drug formulations. According to insights published
India’s pharmaceutical industry is advancing toward high-science, innovation-driven Active Pharmaceutical Ingredient (API) development as HRV Pharma and Shodhana Laboratories announced a strategic multi-year Contract Development and Manufacturing (CDMO) partnership to
The global pharmaceutical manufacturing landscape is witnessing a major investment as Eli Lilly and Company announced plans to build a $6 billion manufacturing facility dedicated to Active Pharmaceutical Ingredients (APIs).
India’s pharmaceutical sector is undergoing a structural shift as the government intensifies its focus on reducing import dependency for Active Pharmaceutical Ingredients (APIs), Key Starting Materials (KSMs), and Drug Intermediates
How can we help you?
Reach out to discuss how our team can help your business achieve real results.
- Why Choose us?
- Experienced Experts with Diverse Industry Backgrounds.
- A record of delivering insightful and actionable recommendations.
- Tailored methodologies to address the client's unique requirements.
- End-to-End Services - market analysis, consumer behaviour, competitive intelligence, and strategic recommendations.
- Advanced tools and technology are used to produce insightful and comprehensive reports.
- Global research capability backed by a network of subject-matter experts and regional partners.
- In-depth knowledge of international markets, regulations, and trends.
- Work closely with the client to identify their specific needs and deliver custom insights.
- Value-focused through efficient and high-quality research outcomes.
